Aidoc vs HOPPR (2026)
Two platforms at different altitudes, and putting them side by side is the point. Aidoc is what a health system buys: an operating system running detection models across an imaging estate with normalisation, monitoring and governance, plus its own clearances. HOPPR is what the companies building those models buy, a multimodal foundation model and development environment for imaging AI, with model transparency among the strongest in the index and a stated consent basis for its training data. Nobody chooses between them. What the pair shows is that a hospital evaluating imaging AI is increasingly evaluating a stack, and the foundation layer where representativeness is decided is the one nobody in the purchasing chain can see.
- It runs detection models across an imaging estate through an operating system handling normalisation, monitoring and governance for every model on it.
- The 2026 clearance covers many acute indications from a single named foundation model, with regulator reviewed performance behind it.
- For a health system, the platform is the durable purchase rather than any individual algorithm.
- It is the layer beneath the applications, a multimodal foundation model and development environment sold to developers, AI companies and imaging vendors.
- Model and technology disclosure is among the strongest in this index, which is the right posture when others build regulated products on it.
- The consent basis for training data is stated rather than implied, which almost nothing in this lane does.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Aidoc and HOPPR are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Aidoc its top capability grade on several axes, including AI Centrality, Autonomy and Oversight Model and Model and Technology Transparency. Set against HOPPR, Aidoc grades higher on several axes, including Autonomy and Oversight Model, Clinical and Operational Evidence and AI Safety and PHI Stewardship. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards HOPPR its top capability grade on AI Centrality, Model and Technology Transparency and Model Supply Chain Disclosure. Set against Aidoc, HOPPR does not grade higher on any scored axis, though the two are level on several axes, including AI Centrality, Model and Technology Transparency and Model Supply Chain Disclosure. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Aidoc or HOPPR?
The AI Health Index grades Aidoc higher than HOPPR on every axis that separates them, several axes, including Autonomy and Oversight Model, Clinical and Operational Evidence and AI Safety and PHI Stewardship. HOPPR does not grade higher on any scored axis.
Where do Aidoc and HOPPR differ most?
The widest separation the AI Health Index records between Aidoc and HOPPR is on Autonomy and Oversight Model, where Aidoc grades A and HOPPR grades C. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do Aidoc and HOPPR grade the same?
The AI Health Index grades Aidoc and HOPPR the same on several axes, including AI Centrality, Model and Technology Transparency and Model Supply Chain Disclosure. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Radiology & Imaging AI page.
These are not alternatives, since one is bought by a health system and the other by the companies building what health systems buy, and the comparison exists to make that layering visible. The risk at the foundation layer is different in kind: a model trained on an unrepresentative corpus carries that variation into every downstream product, and neither the developer nor the eventual hospital buyer will see where it came from. HOPPR publishes no subgroup analysis or model card describing training data composition, and neither vendor publishes pricing.